Prosecution Insights
Last updated: May 29, 2026

Examiner: RAMIREZ, DELIA M

Tech Center 1700 • Art Units: 1652 1799

This examiner grants 65% of resolved cases

Performance Statistics

65.0%
Allow Rate
At TC average
895
Total Applications
+56.5%
Interview Lift
1016
Avg Prosecution Days
Based on 839 resolved cases, 2023–2026

Rejection Statute Breakdown

0.7%
§101 Eligibility
14.5%
§102 Novelty
34.6%
§103 Obviousness
30.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18402269 DECOLORIZING COMPOSITION INCLUDING DICYANDIAMIDE AND HYDROGEN PEROXIDE AND DECOLORIZING METHOD USING THE SAME Non-Final OA CJ CHEILJEDANG CORPORATION
17786913 BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS Final Rejection The Regents of the University of California
17998703 IMPROVED METHOD FOR THE PRODUCTION OF ISOPRENOIDS Non-Final OA BASF SE
18297366 DETERGENT COMPOSITIONS CONTAINING ENZYMES Final Rejection The Procter & Gamble Company
16771794 USE OF A COMBINATION OF TET EXOPROTEASES OBTAINED FROM EXTREMOPHILIC MICROORGANISMS FOR HYDROLYZING POLYPEPTIDES Final Rejection UNIVERSITE GRENOBLE ALPES
16772269 CAS12B SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED RNA BASE EDITING Non-Final OA MASSACHUSETTS INSTITUTE OF TECHNOLOGY
18621960 DNase I Variants, Compositions, Methods, and Kits Non-Final OA New England Biolabs, Inc.
17819100 Dynamic control over multiple host proteases in a genetically modifiel microorganism Non-Final OA Duke University
17459166 ENGINEERED PROTEINS AND METHODS OF USE THEREOF Non-Final OA Pairwise Plants Services, Inc.
18718677 PRODUCTION OF ALPHA-1,3-FUCOSYLATED COMPOUNDS Non-Final OA INBIOSE N.V.
17961007 BACILLUS GIBSONII-CLADE SERINE PROTEASES Final Rejection Danisco US Inc.
16450825 NOVEL CRISPR ENZYMES AND SYSTEMS Final Rejection The United States of America, as Represented by the Secretary, Dept. of Health and Human Services
16450852 NOVEL CRISPR ENZYMES AND SYSTEMS Final Rejection The United States of America, as Represented by the Secretary, Dept. of Health and Human Services
18013047 Improved Export of Oligosaccharides From Bacterial Cells Non-Final OA Chr. Hansen A/S
17285539 CORYNEFORM BACTERIA FOR PROVISION OF MALONYL-COA Non-Final OA Forschungszentrum Jülich GmbH
18032973 METHOD OF CONTROLLING TOTAL SIALIC ACID CONTENT (TSAC) DURING MANUFACTURING OF ALKALINE PHOSPHATASE Final Rejection Alexion Pharmaceuticals, Inc.
18501492 SYSTEM AND METHOD FOR PRODUCING A SUGAR STREAM Non-Final OA Fluid Quip Technologies, LLC
18548325 INSECT-DERIVED ASPARTATE DECARBOXYLASES AND VARIANTS THEREOF FOR IMPROVED BETA-ALANINE PRODUCTION Non-Final OA MOJIA BIOTECH LTD.
17277585 PROCESS FOR CONTROLLING A FERMENTATION PROCESS Non-Final OA FermentationExperts A/S
18033787 Novel Variants of Endonuclease V and Uses Thereof Non-Final OA DNA Script
18003025 PICHIA CIFERRII MUTANT STRAIN HAVING IMPROVED SPHINGOLIPID AND SPHINGOID BASE PRODUCTIVITY, AND PREPARATION METHOD THEREFOR Non-Final OA Croda Korea Ltd
17926572 PROCESS FOR EXTRACTING A HYALURONIC ACID FROM A FUNGUS, A HYALURONIC ACID OF PLANT ORIGIN AND USE THEREOF Final Rejection VIVATIS PHARMA GMBH
17270690 Method for Producing Biodegradable Polymer Non-Final OA MOHARRAM VENTURES INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month